Pharmacological Therapies for COVID-19

Details

Files

Project Line:

Health Technology Review

Project Sub Line:

Technology Review

This report identifies and summarizes published guidance from Canadian jurisdictions that provide recommendations regarding which pharmacological therapies should (or should not) be used to treat COVID-19 across different severities of illness (i.e., critically ill, moderate to severely ill, mildly ill). In total, 40 publications from several Canadian jurisdictions were included and summarized.

Files

Pharmacological Therapies for COVID-19 View PDF

Last Updated : April 27, 2022